文献速递免疫规划传染病防控与疫情报告

强毒与弱毒株制备的全菌灭活钩端螺旋体疫苗在仓鼠模型中的保护效力比较

Protective efficacy of whole-cell inactivated Leptospira vaccines made using virulent or avirulent strains in a hamster model.
PubMed 文献 · Vaccine · 2021-08-13

本研究在仓鼠模型中比较了用弱毒(标准传代)株与强毒株制备的全菌灭活疫苗对致死性攻击的保护效力。结果显示,弱毒Canicola株与强毒株均诱导100%同源保护,而弱毒Copenhageni株仅产生25-37.5%保护(P>0.05),强毒Copenhageni株则达100%保护(P<0.001)。单剂即可诱导保护,加强免疫可降低肾脏菌载并改善体液免疫。

要点

  • 弱毒Copenhageni株疫苗同源保护仅25-37.5%,强毒株达100%。
  • 弱毒与强毒Canicola株疫苗均诱导100%同源保护。
  • 单剂即可保护,加强免疫降低肾脏菌载并增强体液免疫。

核心结论

  • 在疫苗配方中维持强毒株对于提高钩端螺旋体疫苗的免疫原性和效力至关重要。

研究设计与样本

  • 仓鼠模型比较研究,用弱毒与强毒株制备全菌灭活疫苗,评估同源与异源致死攻击保护。

主要发现

  • 弱毒与强毒Canicola株疫苗均诱导100%同源保护。
  • 弱毒Copenhageni株疫苗同源保护仅25-37.5%(P>0.05),强毒株达100%(P<0.001)。
  • 单剂即可诱导保护,加强免疫显著降低肾脏菌载并改善对强毒Copenhageni株的体液免疫。

关键数值与推荐

  • 弱毒Copenhageni株疫苗同源保护25-37.5%(P>0.05)。
  • 强毒Copenhageni株疫苗同源保护100%(P<0.001)。
  • 弱毒与强毒Canicola株疫苗同源保护均100%。

临床怎么用

  • 提示钩端螺旋体灭活疫苗生产应保留强毒株以保障免疫原性与保护效力。
  • 单剂接种可诱导保护,加强免疫有助于降低肾脏菌载并增强抗体应答。

局限性

  • 研究仅基于仓鼠模型,结论外推至人或其他动物需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Whole-cell inactivated vaccines remain the only licensed vaccines used to control human and animal leptospirosis worldwide. Although they are protective against lethal infections, the efficacy of these vaccines has been divergent. The manufacturing process often involves the use of standard bacterial strains subjected to serial in vitro passages, with a risk of loss of virulence, and may affect the immunogenicity and consequently decrease protection. Thus, the objective of this study was to perform a comparative analysis of the efficacy of in-house bacterins produced with standard (avirulent) and virulent strains. Hamsters were immunized with killed bacteria produced using avirulent and virulent strains of L. interrogans serovars Copenhageni and Canicola. Vaccine efficacy was determined in terms of protection against lethal homologous or heterologous challenges. The results showed that immunization with both avirulent and virulent Canicola strains resulted in 100% protection against homologous challenge. Conversely, Copenhageni bacterins produced using an avirulent strain conferred only 25-37.5% protection against homologous challenge (P > 0.05), while virulent Copenhageni bacterin conferred 100% protection (P < 0.001). A single vaccine dose was sufficient to induce protection, and administration of a prime boost significantly reduced the bacterial load in the kidneys and improved the humoral immune response to the virulent Copenhageni strain. These findings suggest that the maintenance of virulent strains in bacterin formulations is essential for improving the immunogenicity and efficacy of leptospirosis vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Rodrigues de Oliveira N, Jorge S, Andrade Colares Maia M, et al. Protective efficacy of whole-cell inactivated Leptospira vaccines made using virulent or avirulent strains in a hamster model. Vaccine. 2021. PMID: 34400016. doi:10.1016/j.vaccine.2021.08.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。